+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Menopausal Hot Flashes Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715539
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Menopausal Hot Flashes Market is undergoing a fundamental transformation, as organizations navigate evolving patient expectations, regulatory shifts, and advances in treatment options. This market analysis equips senior leaders with the strategic insights necessary to optimize clinical and commercial outcomes in an increasingly complex care landscape.

Market Snapshot: Menopausal Hot Flashes Market

The Menopausal Hot Flashes Market grew from USD 9.20 billion in 2025 to USD 9.85 billion in 2026. It is expected to continue expanding at a CAGR of 6.59%, reaching USD 14.39 billion by 2032. This growth reflects heightened attention from healthcare providers, payers, and product developers responding to the persistent prevalence and impact of vasomotor symptoms during the menopausal transition.

Scope & Segmentation

  • Therapeutic Approaches: Traditional hormonal therapies, non-hormonal pharmacotherapies including SSRIs, clonidine, and gabapentin, and complementary therapies such as Black Cohosh, Dong Quai, and isoflavones.
  • Treatment Modalities: Oral, topical, and transdermal formulations; transdermal and topical drug delivery technologies supporting patients with specific comorbidities.
  • Distribution Channels: Clinics, hospital pharmacies (public and private), digital retailers (including company websites and large e-commerce platforms).
  • Patient Age Groups: Women aged 40–50 (early symptom management), 51–60 (integrated care with metabolic/cardiovascular focus), and 60+ (tailored therapies for comorbidity and polypharmacy).
  • Geographic Regions: Americas, Europe-Middle East-Africa, Asia-Pacific, each with distinct clinical practices, regulatory profiles, and access pathways.
  • Emerging Technologies: Digital health platforms, telemedicine, remote symptom tracking, adherence programs integrated into broader patient support solutions.

Key Takeaways

  • Clinical practice is adapting to patient demand for tolerable, convenient, and sustained symptom control, driving a shift toward diverse therapy classes and personalized care strategies.
  • Distribution dynamics are increasingly omnichannel, with hospital pharmacies and digital platforms both playing critical roles in therapy access and patient engagement.
  • Segmented patient needs reveal opportunities to tailor interventions and channel strategies, especially for women with comorbidities, early symptom onset, or preferences for natural products.
  • Safety perceptions and updated treatment guidelines are influencing prescriber and patient choices, reinforcing the value of ongoing evidence generation and clear risk communication.
  • Partnerships, real-world evidence collection, and digital patient support systems are enhancing product differentiation and continuity of care from diagnosis through long-term management.

Tariff Impact

Tariff adjustments introduced by United States authorities in 2025 have added complexity to pharmaceutical supply chains for menopausal hot flash therapies. These changes increased costs for active ingredients and finished forms, prompting manufacturers to revise sourcing strategies and invest in regional manufacturing. In turn, procurement teams and online retailers have responded by consolidating suppliers and optimizing contracting terms to manage cost pressures and maintain patient access, particularly where reimbursement is sensitive to landed product price. As a result, scenario planning and agile supply chain strategies have become essential for maintaining supply continuity and minimizing patient disruption during global trade volatility.

Methodology & Data Sources

This analysis drew from a systematic clinical literature review, regulatory and public health guidance, targeted stakeholder interviews, and in-depth supply chain evaluation. Data collection prioritized recent randomized controlled trials, official policy releases, and structured interviews with clinicians, procurement officials, and digital health providers. Insights were triangulated with public documents to ensure robust and credible findings.

Why This Report Matters

  • Gain actionable strategies to align product development, sourcing, and patient support with evolving clinical and regulatory trends.
  • Identify targeted opportunities by understanding segmentation signals, regional dynamics, and emerging patient preferences across therapy and distribution channels.
  • Support scenario-based planning to safeguard supply resilience and optimize stakeholder communications in response to external impacts such as tariffs or trade disruptions.

Conclusion

Effectively managing menopausal hot flashes demands coordinated clinical, commercial, and supply efforts. Companies that link evidence-based practice, adaptive sourcing, and integrated patient support are positioned to achieve sustained leadership in this growing market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Menopausal Hot Flashes Market, by Product Type
8.1. Complementary Therapy
8.1.1. Black Cohosh
8.1.2. Dong Quai
8.1.3. Isoflavones
8.2. Hormonal Therapy
8.2.1. Combined Estrogen-Progestin Therapy
8.2.2. Estrogen Therapy
8.2.2.1. Oral Estrogen
8.2.2.2. Topical Estrogen
8.2.2.3. Transdermal Estrogen
8.2.3. Selective Estrogen Receptor Modulators
8.3. Non-Hormonal Therapy
8.3.1. Clonidine
8.3.2. Gabapentin
8.3.3. SSRIs
8.3.3.1. Fluoxetine
8.3.3.2. Paroxetine
8.3.3.3. Sertraline
9. Menopausal Hot Flashes Market, by Distribution Channel
9.1. Clinics
9.2. Hospital Pharmacies
9.2.1. Private Hospitals
9.2.2. Public Hospitals
9.3. Online Retailers
9.3.1. Company Websites
9.3.2. E-Commerce Platforms
10. Menopausal Hot Flashes Market, by Age Group
10.1. 40 To 50
10.2. 51 To 60
10.3. Above 60
11. Menopausal Hot Flashes Market, by Region
11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific
12. Menopausal Hot Flashes Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Menopausal Hot Flashes Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. United States Menopausal Hot Flashes Market
15. China Menopausal Hot Flashes Market
16. Competitive Landscape
16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. AbbVie Inc.
16.6. Astellas Pharma Inc.
16.7. Bayer AG
16.8. Besins Healthcare
16.9. Cipla Ltd.
16.10. Endoceutics Inc.
16.11. Ferring International Center S.A.
16.12. GlaxoSmithKline plc
16.13. Hisamitsu Pharmaceutical Co., Ltd.
16.14. Lupin Ltd.
16.15. Millendo Therapeutics, Inc.
16.16. Mithra Pharmaceuticals SA
16.17. Novartis AG
16.18. Novo Nordisk A/S
16.19. Organon & Co.
16.20. Pfizer Inc.
16.21. Sun Pharmaceutical Industries Ltd.
16.22. Teva Pharmaceutical Industries Ltd.
16.23. Theramex Ltd.
16.24. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MENOPAUSAL HOT FLASHES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MENOPAUSAL HOT FLASHES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY BLACK COHOSH, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY BLACK COHOSH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY BLACK COHOSH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DONG QUAI, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DONG QUAI, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DONG QUAI, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ISOFLAVONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ISOFLAVONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ISOFLAVONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMBINED ESTROGEN-PROGESTIN THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMBINED ESTROGEN-PROGESTIN THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMBINED ESTROGEN-PROGESTIN THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ORAL ESTROGEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ORAL ESTROGEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ORAL ESTROGEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TOPICAL ESTROGEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TOPICAL ESTROGEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TOPICAL ESTROGEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TRANSDERMAL ESTROGEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TRANSDERMAL ESTROGEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TRANSDERMAL ESTROGEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY SELECTIVE ESTROGEN RECEPTOR MODULATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY SELECTIVE ESTROGEN RECEPTOR MODULATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY SELECTIVE ESTROGEN RECEPTOR MODULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY CLONIDINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY CLONIDINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY CLONIDINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY GABAPENTIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY GABAPENTIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY GABAPENTIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY FLUOXETINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY FLUOXETINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY FLUOXETINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PAROXETINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PAROXETINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PAROXETINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY SERTRALINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY SERTRALINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY SERTRALINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY 40 TO 50, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY 40 TO 50, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY 40 TO 50, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY 51 TO 60, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY 51 TO 60, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY 51 TO 60, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ABOVE 60, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ABOVE 60, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ABOVE 60, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 141. EUROPE MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. EUROPE MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. EUROPE MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 144. EUROPE MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 148. EUROPE MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. EUROPE MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 150. EUROPE MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 151. EUROPE MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 163. AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 166. AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 167. AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 168. AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 169. AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 170. AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 172. AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 173. AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. ASEAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 189. ASEAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 191. ASEAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 192. ASEAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 193. ASEAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. ASEAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 195. ASEAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 196. ASEAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 197. GCC MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GCC MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 199. GCC MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 200. GCC MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 201. GCC MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 202. GCC MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 203. GCC MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 204. GCC MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 205. GCC MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 206. GCC MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 207. GCC MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 219. BRICS MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. BRICS MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. BRICS MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 222. BRICS MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 223. BRICS MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 224. BRICS MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 225. BRICS MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 226. BRICS MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 227. BRICS MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 228. BRICS MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 229. BRICS MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 230. G7 MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. G7 MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 232. G7 MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 233. G7 MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 234. G7 MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 235. G7 MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 236. G7 MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 237. G7 MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 238. G7 MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 239. G7 MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 240. G7 MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 241. NATO MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 242. NATO MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 243. NATO MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 244. NATO MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 245. NATO MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 246. NATO MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 247. NATO MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 248. NATO MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 249. NATO MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 250. NATO MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 251. NATO MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 252. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 264. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 265. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 266. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COMPLEMENTARY THERAPY, 2018-2032 (USD MILLION)
TABLE 267. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 268. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN THERAPY, 2018-2032 (USD MILLION)
TABLE 269. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL THERAPY, 2018-2032 (USD MILLION)
TABLE 270. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY SSRIS, 2018-2032 (USD MILLION)
TABLE 271. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 272. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 273. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE RETAILERS, 2018-2032 (USD MILLION)
TABLE 274. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Menopausal Hot Flashes market report include:
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Besins Healthcare
  • Cipla Ltd.
  • Endoceutics Inc.
  • Ferring International Center S.A.
  • GlaxoSmithKline plc
  • Hisamitsu Pharmaceutical Co., Ltd.
  • Lupin Ltd.
  • Millendo Therapeutics, Inc.
  • Mithra Pharmaceuticals SA
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co.
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Theramex Ltd.
  • Viatris Inc.

Table Information